News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,402 Results
Type
Article (52451)
Company Profile (371)
Press Release (614580)
Section
Business (186961)
Career Advice (2513)
Deals (33294)
Drug Delivery (113)
Drug Development (81404)
Employer Resources (152)
FDA (16269)
Job Trends (14568)
News (325679)
Policy (32039)
Tag
Academia (2830)
Alliances (47781)
Alzheimer's disease (1411)
Approvals (16234)
Artificial intelligence (233)
Bankruptcy (350)
Best Places to Work (11521)
Biotechnology (288)
Breast cancer (241)
Cancer (1844)
Cardiovascular disease (149)
Career advice (2115)
CAR-T (139)
Cell therapy (394)
Clinical research (65375)
Collaboration (729)
Compensation (302)
COVID-19 (2665)
C-suite (187)
Data (1716)
Diabetes (227)
Diagnostics (6242)
Earnings (69314)
Employer resources (138)
Events (101280)
Executive appointments (615)
FDA (17245)
Funding (648)
Gene therapy (287)
GLP-1 (729)
Government (4566)
Healthcare (19282)
Infectious disease (2790)
Inflammatory bowel disease (137)
Interviews (529)
IPO (15321)
Job creations (3511)
Job search strategy (1744)
Layoffs (460)
Legal (7169)
Lung cancer (272)
Manufacturing (237)
Medical device (14027)
Medtech (14031)
Mergers & acquisitions (18355)
Metabolic disorders (619)
Neuroscience (1875)
NextGen: Class of 2025 (6728)
Non-profit (4567)
Northern California (2114)
Obesity (338)
Opinion (232)
Patents (180)
People (57913)
Phase I (20434)
Phase II (28773)
Phase III (21507)
Pipeline (799)
Postmarket research (2605)
Preclinical (8664)
Radiopharmaceuticals (260)
Rare diseases (358)
Real estate (5416)
Regulatory (22181)
Research institute (2487)
Resumes & cover letters (364)
Southern California (1859)
Startups (3595)
United States (18983)
Vaccines (635)
Weight loss (251)
Date
Today (133)
Last 7 days (801)
Last 30 days (2742)
Last 365 days (34714)
2025 (5432)
2024 (35504)
2023 (39944)
2022 (51065)
2021 (55252)
2020 (53906)
2019 (46957)
2018 (35479)
2017 (32615)
2016 (31676)
2015 (37022)
2014 (29497)
2013 (24697)
2012 (26269)
2011 (26875)
2010 (24895)
Location
Africa (839)
Arizona (188)
Asia (40235)
Australia (7557)
California (4903)
Canada (1732)
China (417)
Colorado (224)
Connecticut (239)
Europe (89527)
Florida (724)
Georgia (169)
Illinois (481)
Indiana (266)
Maryland (793)
Massachusetts (3706)
Michigan (204)
Minnesota (353)
New Jersey (1418)
New York (1392)
North Carolina (893)
Northern California (2114)
Ohio (172)
Pennsylvania (1088)
South America (1140)
Southern California (1859)
Texas (698)
Utah (155)
Washington State (466)
667,402 Results for "precision therapeutics formerly known as skyline medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
February 20, 2025
·
4 min read
Press Releases
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
January 14, 2025
·
4 min read
Press Releases
Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit
February 25, 2025
·
6 min read
Press Releases
Spectra Medical, XL Precision Technologies Announce Rebrand as Elevaris Medical Devices
January 28, 2025
·
3 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Press Releases
Skyline Therapeutics’ Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa
September 3, 2024
·
3 min read
Press Releases
Precision Neuroscience Expands Clinical Research in Brain–Computer Interface Through Collaboration with Beth Israel Deaconess Medical Center
February 27, 2025
·
2 min read
Drug Development
Beacon Therapeutics Announces Positive 24-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa
October 15, 2024
·
4 min read
1 of 66,741
Next
